» Articles » PMID: 3863118

Dose-repetition Increases the Mutagenic Effectiveness of N-ethyl-N-nitrosourea in Mouse Spermatogonia

Overview
Specialty Science
Date 1985 Oct 1
PMID 3863118
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

In order to maximize the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse stem-cell spermatogonia, advantage was taken of the fact that these cells can accumulate mutations from repeated doses given over relatively long time periods. Repeated doses (100 mg/kg) of ethylnitrosourea injected intraperitoneally into male mice at weekly intervals were found to allow adequate survival and fertility with total dosages of 300 and 400 mg/kg. The specific-locus mutation frequencies at these dosages were, respectively, 1.8 and 2.2 times that obtained with the maximal practicable single dose of 250 mg/kg. The mutation frequency induced by a 400 mg/kg dosage of ethylnitrosourea is 12 times the maximal mutation frequency achievable with a single exposure to x-rays and 36 times that reported for procarbazine, the most effective chemical mutagen previously known for mouse stem-cell spermatogonia. Ethylnitrosourea is already the mutagen of choice in deliberate attempts to create mouse models for human disease and in any experiments in which a maximal mutation rate is desired. Repeated-dose regimens similar to the ones reported here should increase the efficiency of such studies.

Citing Articles

New advances in CRISPR/Cas-mediated precise gene-editing techniques.

Richardson C, Kelsh R, Richardson R Dis Model Mech. 2023; 16(2).

PMID: 36847161 PMC: 10003097. DOI: 10.1242/dmm.049874.


The molecular underpinnings of fertility: Genetic approaches in .

Mei X, Singson A Adv Genet (Hoboken). 2021; 2(1).

PMID: 34322672 PMC: 8315475. DOI: 10.1002/ggn2.10034.


Suppressor mutations in -null mice implicate the DNA damage response in Rett syndrome pathology.

Enikanolaiye A, Ruston J, Zeng R, Taylor C, Schrock M, Buchovecky C Genome Res. 2020; 30(4):540-552.

PMID: 32317254 PMC: 7197480. DOI: 10.1101/gr.258400.119.


Studies on the Small Body Size Mouse Developed by Mutagen -Ethyl--nitrosourea.

Zhang Q, Cho K, Cho J, Cha D, Park H, Yoon S Toxicol Res. 2020; 24(1):69-78.

PMID: 32038779 PMC: 7006338. DOI: 10.5487/TR.2008.24.1.069.


Studies on -Ethyl--nitrosourea Mutagenesis in BALB/c Mice.

Cho K, Cho J, Song C Toxicol Res. 2020; 24(1):59-68.

PMID: 32038778 PMC: 7006260. DOI: 10.5487/TR.2008.24.1.059.


References
1.
Selby P, Niemann S . Non-breeding-test methods for dominant skeletal mutations shown by ethylnitrosourea to be easily applicable to offspring examined in specific-locus experiments. Mutat Res. 1984; 127(1):93-105. DOI: 10.1016/0027-5107(84)90144-1. View

2.
RUSSELL W, Kelly E, Hunsicker P, BANGHAM J, Maddux S, Phipps E . Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci U S A. 1979; 76(11):5818-9. PMC: 411742. DOI: 10.1073/pnas.76.11.5818. View

3.
RUSSELL W . X-ray-induced mutations in mice. Cold Spring Harb Symp Quant Biol. 1951; 16:327-36. DOI: 10.1101/sqb.1951.016.01.024. View

4.
RUSSELL W, Hunsicker P, Raymer G, STEELE M, STELZNER K, Thompson H . Dose--response curve for ethylnitrosourea-induced specific-locus mutations in mouse spermatogonia. Proc Natl Acad Sci U S A. 1982; 79(11):3589-91. PMC: 346467. DOI: 10.1073/pnas.79.11.3589. View

5.
Goodfellow P . Of man and mouse. Nature. 1985; 314(6007):135. DOI: 10.1038/314135a0. View